Maze Therapeutics Announces Profitable IPO Filing Maze Therapeutics reveals a profit in its IPO filing, planning to list on Nasdaq under 'MAZE'. Discover more about this promising biotech company's financial prospects.
Biotech IPOs Surge with Strong Performances Explore the booming biotech IPO market, highlighting successful launches from companies like Maze Therapeutics. Discover key trends and opportunities.
Moderna Shares Surge on Bird Flu Vaccine Hopes Moderna shares rise as investors anticipate success in its experimental bird flu vaccine. Explore the potential impact on the biotech market.
Biotech Stocks Surge Amid Health Incidents Explore how recent health-related incidents are driving up biotech stock performance. Discover the investment opportunities in the biotech sector.
Moderna Stock Surges Over 10% Amid Bird-Flu Concerns Moderna shares soar by more than 10% after the first U.S. bird-flu death. Discover how health crises impact biotech stocks.
Healthcare Sector Faces Selloff Amid Political Concerns Explore the healthcare sector's selloff due to political and regulatory concerns impacting hospitals, pharmaceuticals, health insurers, and biotech.
Surrozen Stock Upgraded After Promising Phase 1b Results Surrozen's stock receives a 'Buy' upgrade due to positive results from Phase 1b trials, boosting investor confidence in the biotech company's future prospects.
Guggenheim Upgrades Surrozen on Promising Liver Disease Data Guggenheim upgrades Surrozen (SRZN) following promising Phase 1b trial results for its lead liver disease asset. Explore implications for SRZN stock.
Neumora's Depression Drug Trial Fails, Shares Plunge 82% Neumora Therapeutics' depression drug falls short in final-stage trial, leading to an 82% pre-market share drop. Discover the impact on Neumora's future prospects.
Westchester County's Economic Growth Fueled by Key Sectors Explore Westchester County's economic surge driven by biotech, health care, and retail. Discover the growth factors and key industries shaping the region.